Showing results (191-200 of 211) with videos related to
Sort By:
Pageof 22
Nuclear Medicine and Biology|March 12, 2004
Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude miceMichael R Lewis, Jiuli Zhang, Fang Jia, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 8, 2005
Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion proteinNoriko Sato, Raffit Hassan, Donald B Axworthy, et al.Annals of Neurology|April 25, 2006
Immune surveillance in multiple sclerosis patients treated with natalizumabOlaf Stüve, Christina M Marra, Keith R Jerome, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 24, 2013
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM studyMariko Kita, Robert J Fox, J Theodore Phillips, et al.Neurology and Therapy|December 15, 2015
Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing ExperienceRalf Gold, J Theodore Phillips, Eva Havrdova, et al.Annals of Clinical and Translational Neurology|March 10, 2015
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trialsVissia Viglietta, David Miller, Amit Bar-Or, et al.Bioconjugate Chemistry|November 8, 2011
Comparison of pretargeted and conventional CC49 radioimmunotherapy using 149Pm, 166Ho, and 177LuHuma Mohsin, Fang Jia, Jeffrey N Bryan, et al.The New England Journal of Medicine|March 3, 2006
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosisChris H Polman, Paul W O'Connor, Eva Havrdova, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Pretargeted alpha emitting radioimmunotherapy using (213)Bi 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-biotinZhengsheng Yao, Meili Zhang, Kayhan Garmestani, et al.Archives of Neurology|October 13, 2006
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosisOlaf Stüve, Christina M Marra, Amit Bar-Or, et al.Pageof 22